Erstellt von fchar99
Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Corp.
WKN: 936853 / Symbol: EW / Name: Edwards Lifesciences / Aktie / Ausrüstung & Versorgung / Large Cap /
80,00 €
1,25 %
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $80.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $94.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Mizuho from $85.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $82.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Morgan Stanley from $80.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Morgan Stanley from $95.00 to $103.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at OTR Global from a "mixed" rating to a "positive" rating.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Mizuho from $95.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Royal Bank of Canada from $95.00 to $101.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Wells Fargo & Company from $94.00 to $99.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Barclays PLC from $100.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Home Depot Inc. diskutieren